Parkside Investments’s Eli Lilly LLY Stock Holding History

Parkside Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000	Closed	-$687K	–	92
2023 Q1	$687K	Buy	+2,000	New	+$675K	0.13%	70

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Parkside Investments's LLY Position: Q2 2023 in Review

Parkside Investments sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 2,000 shares — an estimated $687K sold.

Parkside Investments first reported a position in LLY in Q1 2023 and held it in 1 quarter. The position peaked at $687K in Q1 2023. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

Parkside Investments reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
Parkside Investments sold 2,000 Eli Lilly shares in Q2 2023, an estimated $687K.
Parkside Investments first reported a position in Eli Lilly in Q1 2023 and held it in 1 quarter.
Parkside Investments's Eli Lilly position peaked at $687K in Q1 2023.
2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Parkside Investments's 13F filing for Q2 2023, filed 7 Jul 2023.